Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New Jersey · 2026-2027 Regular Session · Bill

A 1636: Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 1636 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance. Primary sponsor: Sean Kean (Republican). Most recent recorded action (January 13, 2026): Introduced, Referred to Assembly Consumer Affairs Committee.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Republican 1

NameRolePartyChamberDistrict
Sean KeanPrimary sponsorRepublicanHouse30

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Introduced, Referred to Assembly Consumer Affairs Committee

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source